July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Kimryn Rathmell: Engineering a STING Agonist-Powered Immune Response with Nanobody Conjugates
Jun 13, 2025, 09:35

Kimryn Rathmell: Engineering a STING Agonist-Powered Immune Response with Nanobody Conjugates

Kimryn Rathmell, CEO of Ohio State’s James Cancer Hospital and Solove Research Institute, shared a post on X by Immunoengineering Lab, about a paper she co-authored with colleagues published in Nature Biomedical Engineering:

“Delighted to see this in print, and glad to have been on the team. Super cool science with immediate implications for treatment paradigms – using nanobodies to engineer a STING agonist-powered response of the innate immune system to cancer. Congrats, Immunoengineering Lab, and well done!”

Quoting Immunoengineering Lab’s post:

“Excited to share our latest publication in Nature Biomedical Engineering! Big congrats to all co-authors on this highly collaborative effort – especially to the first author, Blaise Kimmel, for his dedication to this project! Check out the paper (open access).”

Title: Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody–STING agonist conjugates

Authors: Blaise R. Kimmel, Karan Arora, Neil C. Chada, Vijaya Bharti, Alexander J. Kwiatkowski, Jonah E. Finkelstein, Ann Hanna, Emily N. Arner, Taylor L. Sheehy, Lucinda E. Pastora, Jinming Yang, Hayden M. Pagendarm, Payton T. Stone, Ebony Hargrove-Wiley, Brandie C. Taylor, Lauren A. Hubert, Barbara M. Fingleton, Katherine N. Gibson-Corley, Jody C. May, John A. McLean, Jeffrey C. Rathmell, Ann Richmond, W. Kimryn Rathmell, Justin M. Balko, John T. Wilson

Kimryn Rathmell: Engineering a STING Agonist-Powered Immune Response with Nanobody Conjugates

You can read the Full Article in Nature Biomedical Engineering.

More posts featuring Kimryn Rathmell.